Recalls / Active ingredient / Levofloxacin

Levofloxacin

11 FDA drug recalls involving the active ingredient “Levofloxacin” — 1 Class I.

Date	Class	Product	Firm
2022-04-13	Class II	Levofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61	Mckesson Medical-Surgical Inc. Corporate Office
2021-03-15	Class II	Levofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose Flexible C	Cardinal Health Inc.
2018-09-25	Class III	Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-	Baxter Healthcare Corporation
2018-08-01	Class III	Levofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single Use Contain	Baxter Healthcare Corporation
2018-08-01	Class III	Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Conta	Baxter Healthcare Corporation
2018-08-01	Class III	Levofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single Use Conta	Baxter Healthcare Corporation
2018-03-27	Class II	Levofloxacin in 5% Dextrose Injection, 250 mg Levofloxacin (5 mg/mL) in 50 mL of 5% Dextrose, For Intravenous	AuroMedics Pharma LLC
2018-03-27	Class II	Levofloxacin in 5% Dextrose Injection, 500 mg Levofloxacin (5 mg/mL) in 100 mL of 5% Dextrose, For Intravenous	AuroMedics Pharma LLC
2018-03-27	Class II	Levofloxacin in 5% Dextrose Injection, 750 mg Levofloxacin (5 mg/mL) in 150 mL of 5% Dextrose, For Intravenous	AuroMedics Pharma LLC
2018-01-12	Class I	Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, M	AuroMedics Pharma LLC
2017-03-10	Class II	Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesc	Claris Lifesciences Inc